Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 24% ± 5% |
Insufficient scRNA-seq data for expression of METTL13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adipose | 100% | 1561.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 100% | 2113.07 | 258 / 258 | 0% | 0 | 0 / 0 |
bladder | 100% | 1576.62 | 21 / 21 | 0% | 0 | 0 / 0 |
breast | 100% | 1678.89 | 459 / 459 | 0% | 0 | 0 / 0 |
esophagus | 100% | 1452.68 | 1445 / 1445 | 0% | 0 | 0 / 0 |
kidney | 100% | 1246.75 | 89 / 89 | 0% | 0 | 0 / 0 |
liver | 100% | 1018.54 | 226 / 226 | 0% | 0 | 0 / 0 |
muscle | 100% | 1464.59 | 803 / 803 | 0% | 0 | 0 / 0 |
ovary | 100% | 1357.85 | 180 / 180 | 0% | 0 | 0 / 0 |
prostate | 100% | 1452.98 | 245 / 245 | 0% | 0 | 0 / 0 |
skin | 100% | 2292.21 | 1809 / 1809 | 0% | 0 | 0 / 0 |
spleen | 100% | 1935.93 | 241 / 241 | 0% | 0 | 0 / 0 |
thymus | 100% | 1449.32 | 653 / 653 | 0% | 0 | 0 / 0 |
uterus | 100% | 1680.96 | 170 / 170 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1201.03 | 1334 / 1335 | 0% | 0 | 0 / 0 |
intestine | 100% | 1567.31 | 965 / 966 | 0% | 0 | 0 / 0 |
pancreas | 100% | 951.85 | 327 / 328 | 0% | 0 | 0 / 0 |
stomach | 99% | 1338.72 | 357 / 359 | 0% | 0 | 0 / 0 |
lung | 99% | 1423.91 | 572 / 578 | 0% | 0 | 0 / 0 |
brain | 99% | 1171.65 | 2610 / 2642 | 0% | 0 | 0 / 0 |
heart | 97% | 968.25 | 838 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 88% | 1237.71 | 821 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032259 | Biological process | methylation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_1902807 | Biological process | negative regulation of cell cycle G1/S phase transition |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0016279 | Molecular function | protein-lysine N-methyltransferase activity |
Gene name | METTL13 |
Protein name | eEF1A lysine and N-terminal methyltransferase (eEF1A-KNMT) (Methyltransferase-like protein 13) [Includes: eEF1A lysine methyltransferase (EC 2.1.1.-); eEF1A N-terminal methyltransferase (EC 2.1.1.-)] |
Synonyms | EEF1AKNMT CGI-01 KIAA0859 FEAT |
Description | FUNCTION: Dual methyltransferase that catalyzes methylation of elongation factor 1-alpha (EEF1A1 and EEF1A2) at two different positions, and is therefore involved in the regulation of mRNA translation . Via its C-terminus, methylates EEF1A1 and EEF1A2 at the N-terminal residue 'Gly-2' . Via its N-terminus dimethylates EEF1A1 and EEF1A2 at residue 'Lys-55' . Has no activity towards core histones H2A, H2B, H3 and H4 . Negatively regulates cell proliferation at G1/S transition via transcriptional suppression of cell cycle regulatory genes such as CDK4 and CDK6 . . |
Accessions | ENST00000367737.9 [Q8N6R0-1] ENST00000362019.7 [Q8N6R0-3] ENST00000361735.4 [Q8N6R0-5] Q8N6R0 |